 | Up a level |
Zeitlberger, A M; Putora, P M; Hofer, S; Schucht, P; Migliorini, D; Hottinger, A F; Roelcke, U; Läubli, H; Spina, P; Bozinov, O; Weller, M; Neidert, M C; Hundsberger, T (2022). Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis. Journal of neuro-oncology, 158(3), pp. 359-367. Springer 10.1007/s11060-022-04022-7
Wirsching, H-G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, Ludwig; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J; ... (2018). Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Annals of oncology, 29(6), pp. 1423-1430. Oxford University Press 10.1093/annonc/mdy120
Hergersberg, M; Mariani, L; Vassella, E; Murtin, C; Weis, J; Moschopulos, M; Laeng, H; Landolt, H; Huber, A; Roelcke, U (2006). Age at diagnosis and loss of heterozygosity on chromosome 1p and 19q in oligodendroglial tumors. Journal of neuro-oncology, 80(2), pp. 215-7. Boston, Mass.: Springer 10.1007/s11060-006-9177-2
